Welcome to LookChem.com Sign In|Join Free

CAS

  • or

519148-16-4

Post Buying Request

519148-16-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

519148-16-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 519148-16-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,1,9,1,4 and 8 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 519148-16:
(8*5)+(7*1)+(6*9)+(5*1)+(4*4)+(3*8)+(2*1)+(1*6)=154
154 % 10 = 4
So 519148-16-4 is a valid CAS Registry Number.

519148-16-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 2,6-bis [(2,2-dimethylpropanoyl)amino]nicotinate

1.2 Other means of identification

Product number -
Other names methyl 2,6-bis[(2,2-dimethylpropanoyl)amino]nicotinate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:519148-16-4 SDS

519148-16-4Relevant articles and documents

IMADAZOPYRIDINE COMPOUNDS HAVING 5-HT4 RECEPTOR AGONISTIC ACTIVITY AND 5-HT3 RECEPTOR ANTAGONISTIC ACTIVITY

-

Page 26-27, (2010/02/09)

This invention provides a compound of the formula (I): wherein R1 represents a hydrogen atom or a halogen atom; R2 represents a methyl group or an ethyl group; or pharmaceutically acceptable salts thereof. These compounds have 5-HT4 receptor agonistic activity and 5-HT3 receptor antagonistic activity, and thus are useful for the treatment of gastroesophageal reflux disease, non-ulcer dyspepsia, functional dyspepsia, irritable bowel syndrome, diabetes or the like in mammalian, especially humans. The present invention also relates to a pharmaceutical composition, a method of treatment and use, comprising the above compounds.

Imidazopyridine compounds as 5-HT4 receptor modulators

-

, (2008/06/13)

This invention provides a compound of the formula (I): 1or the pharmaceutically acceptable salts thereof wherein R1 is hydrogen, halo or alkyl; R2 and R3 are independently hydrogen, alkyl, alkenyl, alkynyl, aminoalkyl or

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 519148-16-4